AC
COYA icon

AXQ Capital’s Coya Therapeutics COYA Stock Holding History

AXQ Capital’s Portfolio COYA Stock Details COYA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$116K Buy
+19,809
New +$91.7K 0.01% 813

Other funds holding COYA

DCM
DME Capital Management New York $3.91B AUM 36.1% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $38.9B AUM 28.51% 1-Year Est. Return
ACM
AIGH Capital Management Baltimore, Maryland $1.59B AUM 855.46% 1-Year Est. Return
CM
CM Management Gulf Breeze, Florida $157M AUM 60.08% 1-Year Est. Return
PMG
Private Management Group Irvine, California $3.8B AUM 23.19% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
PM
Prosight Management Dallas, Texas $580M AUM 29.81% 1-Year Est. Return

AXQ Capital's COYA Position: Q2 2026 in Review

AXQ Capital opened a new position in Coya Therapeutics (COYA) in Q2 2026: 19,809 shares worth $116K. The stake represents 0.01% of the portfolio and ranks #813 among its holdings.

54 funds tracked by Wall St. Rank hold COYA as of Q2 2026.

  • AXQ Capital held 19,809 shares of Coya Therapeutics worth $116K as of Q2 2026.
  • Coya Therapeutics was a new AXQ Capital position in Q2 2026.
  • Coya Therapeutics made up 0.01% of AXQ Capital's portfolio in Q2 2026, its #813 holding.
  • 54 funds tracked by Wall St. Rank held Coya Therapeutics as of Q2 2026.

Based on AXQ Capital's 13F filing for Q2 2026, filed 6 Aug 2026.